The Oncology Institute (The Oncology Institute) Accounts Receivable : $58.8 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is The Oncology Institute Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. The Oncology Institute's accounts receivables for the quarter that ended in Mar. 2024 was $58.8 Mil.

Accounts receivable can be measured by Days Sales Outstanding. The Oncology Institute's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 56.64.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. The Oncology Institute's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-0.64.

The Oncology Institute Accounts Receivable Historical Data

The historical data trend for The Oncology Institute's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Oncology Institute Accounts Receivable Chart

The Oncology Institute Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

14.62

17.15

20.01

39.82

42.36

The Oncology Institute Quarterly Data
	Sep18	Dec18	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Receivable	Get a 7-Day Free Trial														45.96	46.39	48.44	42.36	58.76

The Oncology Institute Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

The Oncology Institute Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

The Oncology Institute's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	58.76	/	94.666	*	91
=	56.64

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), The Oncology Institute's accounts receivable are only considered to be worth 75% of book value:

The Oncology Institute's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(65.832	+	0.75 * 58.76	+	0.5 * 11.554	-	163.236
-	0	-	0)	/	74.3129
=	-0.64

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

The Oncology Institute Accounts Receivable Related Terms

Thank you for viewing the detailed overview of The Oncology Institute's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

The Oncology Institute (The Oncology Institute) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Oncology Institute Inc (NAS:TOI) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703

Website

https://www.theoncologyinstitute.com

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

Executives

Havencrest Healthcare Partners, L.p.	10 percent owner	5221 N. O'CONNOR BLVD., SUITE 1200, IRVING TX 75039
Mihir Shah	officer: Chief Financial Officer, other: Principal Financial Officer	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Brad Hively	director, officer: Chief Executive Officer	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Jeremy Castle	officer: Chief Operating Officer	1800 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Richard A Barasch	director, officer: Executive Chairman	C/O UNIVERSAL AMERICAN FINANCIAL CORP, SIX INTERNATIONAL DRIVE SUITE 190, RYE BROOK NY 10573
Matthew P Miller	officer: Chief Operating Officer	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Daniel Virnich	officer: Chief Operating Officer	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Yale Podnos	officer: Chief Medical Officer	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Diona Simoneit	officer: Chief Accounting Officer, other: Principal Accounting Officer	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Mohit Kaushal	director	44 SOUTH BROADWAY, WHITE PLAINS NY 10601
Gabriel Ling	director	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Mark L Pacala	director	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Richy Agajanian	10 percent owner	C/O THE ONCOLOGY INSTITUTE OF HOPE, 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS CA 90703
Maeve O'meara	director	C/O CASTLIGHT HEALTH, INC., 150 SPEAR ST., SUITE 400, SAN FRANCISCO CA 94105
Toi Hc I, Llc	10 percent owner	2100 MCKINNEY AVENUE, SUITE 1760, DALLAS TX 75201